Armata Pharmaceuticals, Inc. (ARMP)
NYSEAMERICAN: ARMP · Real-Time Price · USD
2.090
+0.110 (5.56%)
Nov 20, 2024, 4:00 PM EST - Market closed

Armata Pharmaceuticals Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2023 FY 2022 FY 2021 FY 2020 FY 2019 2018 - 2017
Period Ending
Nov '24 Dec '23 Dec '22 Dec '21 Dec '20 Dec '19 2018 - 2017
Market Capitalization
76117451485632
Upgrade
Market Cap Growth
-20.88%161.30%-69.80%165.90%72.90%-
Upgrade
Enterprise Value
194207591495327
Upgrade
Last Close Price
2.093.241.245.482.983.25
Upgrade
PS Ratio
13.8225.868.1433.1867.83-
Upgrade
PB Ratio
-1.68-3.651.245.842.962.21
Upgrade
P/TBV Ratio
--1.386.783.632.91
Upgrade
EV/Sales Ratio
35.4545.6610.6933.2364.37-
Upgrade
Debt / Equity Ratio
-2.65-3.751.351.500.700.20
Upgrade
Asset Turnover
0.050.050.070.080.03-
Upgrade
Quick Ratio
0.161.030.942.761.521.24
Upgrade
Current Ratio
0.191.161.093.111.621.36
Upgrade
Return on Equity (ROE)
--3439.35%-120.10%-104.65%-132.62%-174.80%
Upgrade
Return on Assets (ROA)
-24.57%-26.32%-27.89%-27.25%-41.53%-56.22%
Upgrade
Return on Capital (ROIC)
-27.93%-29.51%-31.15%-31.22%-54.55%-89.41%
Upgrade
Earnings Yield
-54.70%-58.95%-82.37%-15.60%-39.73%-60.33%
Upgrade
FCF Yield
-55.65%-47.45%-77.40%-16.76%-34.20%-48.96%
Upgrade
Buyback Yield / Dilution
-0.21%-5.19%-42.27%-46.84%-104.93%-72.15%
Upgrade
Total Shareholder Return
-0.21%-5.19%-42.27%-46.84%-104.93%-72.15%
Upgrade
Source: S&P Capital IQ. Standard template. Financial Sources.